If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

Two lawmakers are accusing the government of improperly redacting some people's names from the Epstein files, including six men whose identities are now public.

First names in Western countries today are more diverse than they were before early modern states evolved. This difference started to emerge in the 17th century in response to a change that took place ...

Khanna and Massie said they “forced” the DOJ to share the identities of six men in the Epstein files that were redacted.

Siblings Domen and Nika Prevc led Slovenia to back-to-back Olympic titles in mixed team normal hill ski jumping on Tuesday at Milan Cortina 2026.

Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.

Cathie Wood’s Ark Invest expanded its Bullish holdings, buying additional shares as the stock surged more than 16% amid a ...

Cathie Wood’s ARK Invest continued trimming its exposure to Coinbase on Friday, selling roughly $22 million worth of shares across three exchange-traded ...

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

It’s a powerful film that has received praise during its festival runs and limited theatrical release in the past couple of ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day.